ChemicalBook--->CAS DataBase List--->166089-33-4

166089-33-4

166089-33-4 Structure

166089-33-4 Structure
IdentificationBack Directory
[Name]

Nagrestipen
[CAS]

166089-33-4
[Synonyms]

Nagrestipen
Human clone pat464 macrophage inflammatory
[Molecular Formula]

C338H516N88O108S4
Hazard InformationBack Directory
[Uses]

Hematopoietic inhibitor.
[in vivo]

Nagrestipen (ECI 301) (i.v; 2 μg; daily for 5 days) significantly inhibits tumor growth at 6 Gy local irradiation of tumor sites and enhances the distant septal effect of radiation in male BALB/c mice[1].
Nagrestipen (ECI 301) (i.v; 0.08, 0.4, 2 μg; day 1,8,15) can inhibit tumor growth in a dose-dependent manner at both irradiated and unirradiated sites of female C57BL/6 with LLC cells[1].

Animal Model:Male BALB/c mice with Colon26 cells and MethA cells[1]
Dosage:2 μg
Administration:Intravenous injection; daily for 5 days
Result:Significantly inhibited tumor size without significant toxicity.
Stopped tumor growth in the colon not only at the irradiated site but also at the unirradiated.
166089-33-4 suppliers list
Company Name: YantaiBio  
Telephone: 13758194781; 13758194781
Website:
Tags:166089-33-4 Related Product Information
7226-77-9 7512-17-6 4105-38-8 136632-28-5 2938875-39-7 181530-09-6